US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veru Inc.

2.46

-0.0100-0.40%

Post-market: 2.490.0300+1.22%18:28 EDT

Volume:203.38K

Turnover:502.75K

Market Cap:41.94M

PE:-4.20

High:2.54

Open:2.42

Low:2.41

Close:2.47

52wk High:7.33

52wk Low:2.05

Shares:17.05M

Float Shares:15.48M

Volume Ratio:0.52

T/O Rate:1.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5854

EPS(LYR):-1.5517

ROE:-64.54%

ROA:-54.03%

PB:1.48

PE(LYR):-1.59

Loading ...

Overview Company News Filings

Veru - to Offer and Sell up to $21.8 Mln of Common Stock Under Sales Agreement - SEC Filing

THOMSON REUTERS

Veru Enters At-the-market Equity Sales Agreement for up to $21.8 Million Stock Offering

Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge

MT Newswires Live

Veru pact with Novo ‘significant event,’ says Canaccord

Veru Is Maintained at Buy by Canaccord Genuity

Veru announces clinical supply agreement with Novo Nordisk

Veru enters clinical supply deal with Novo Nordisk for enobosarm-Wegovy obesity trial

Veru - Enters Clinical Supply Agreement With Novo Nordisk for Phase 2B Plateau Study - SEC Filing

THOMSON REUTERS

Veru - to Provide Novo Nordisk With Insights and Updates on Obesity Trial Design - SEC Filing

THOMSON REUTERS

Veru - Grants Novo Nordisk Right of First Negotiation for Enobosarm in Combination With Any Novo's Glp-1 Products

THOMSON REUTERS

Soccer-FIFA rolls out global initiative to boost female player health and performance

Veru : Oppenheimer Cuts Target Price to $24 From $25

THOMSON REUTERS

Veru Inc. Earnings Call Highlights Clinical Momentum

Veru Inc reports results for the quarter ended March 31 - Earnings Summary

Veru Q2 net loss narrows as expenses decline

Veru Q2 Net Income USD -2.7 Million

THOMSON REUTERS

Veru FY26 Q2 net loss narrows to $2.74 million

Veru Q2 EPS $(0.12) Beats $(0.28) Estimate

Benzinga Earnings

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2B Plateau Clinical Trial Progress

THOMSON REUTERS

Press Release: Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/VERU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VERU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERU\",,,,,undefined,":{"symbol":"VERU","market":"US","secType":"STK","nameCN":"Veru Inc.","latestPrice":2.46,"timestamp":1791403200000,"preClose":2.47,"halted":0,"volume":203377,"hourTrading":{"tag":"盘后","latestPrice":2.49,"preClose":2.46,"latestTime":"18:28 EDT","volume":1215,"amount":3019.0300559999996,"timestamp":1791412097809,"change":0.03,"changeRate":0.012195,"amplitude":0.044715},"delay":0,"changeRate":-0.00404858299595151,"floatShares":15478466,"shares":17050300,"eps":-0.5854,"marketStatus":"Post-Mkt","change":-0.01,"latestTime":"10-07 18:34:07 EDT","open":2.42,"high":2.54,"low":2.41,"amount":502754.6147656,"amplitude":0.052632,"askPrice":2.7,"askSize":200,"bidPrice":2.43,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-0.5854,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.47,"preHourTrading":{"tag":"盘前","latestPrice":2.45,"preClose":2.47,"latestTime":"09:28 EDT","volume":2065,"amount":5079.9109445,"timestamp":1791379682105,"change":-0.02,"changeRate":-0.008097,"amplitude":0.040486},"postHourTrading":{"tag":"盘后","latestPrice":2.49,"preClose":2.46,"latestTime":"18:28 EDT","volume":1215,"amount":3019.0300559999996,"timestamp":1791412097809,"change":0.03,"changeRate":0.012195,"amplitude":0.044715},"volumeRatio":0.517247,"impliedVol":1.4009,"impliedVolPercentile":0.8924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERU\",,,,,undefined,":{"symbol":"VERU","floatShares":15478466,"roa":"-54.03%","roe":"-64.54%","lyrEps":-1.551674,"volumeRatio":0.517247,"shares":17050300,"dividePrice":0,"high":2.54,"amplitude":0.052632,"preClose":2.47,"low":2.41,"week52Low":2.05,"pbRate":"1.48","psRate":"2.48","week52High":7.33,"institutionHeld":0.1516,"latestPrice":2.46,"committee":-0.860465,"eps":-0.5854,"divideRate":0,"volume":203377,"delay":0,"ttmEps":-0.5854,"open":2.42,"prevYearClose":2.14,"prevWeekClose":2.51,"prevMonthClose":2.66,"prevQuarterClose":2.66,"fiveDayClose":2.66,"twentyDayClose":2.48,"sixtyDayClose":2.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VERU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"VERU","fiscalQuarterEnding":"2026/06","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-05-13","symbol":"VERU","fiscalQuarterEnding":"2026/03","expectedEps":-0.37,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2026-02-11","symbol":"VERU","fiscalQuarterEnding":"2025/12","expectedEps":-0.47,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-12-17","symbol":"VERU","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1765947600000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2025-08-12","symbol":"VERU","fiscalQuarterEnding":"2025/06","expectedEps":-0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VERU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VERU\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1766116800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VERU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VERU","date":"2026-10-06","current":-4.202255,"percent":0.349507,"low":-5407.276503,"twenty":-9.219417,"median":-2.408493,"eighty":-0.949497,"high":75.220262,"avg":-156.698758,"sd":826.570136,"marketCap":43478316},"quantilePoints":[{"date":"2021-10-08","current":-4695.938994,"twenty":-18.285252,"median":-7.322209,"eighty":10.141247,"marketCap":674764170},{"date":"2021-10-15","current":-4773.741536,"twenty":-18.435917,"median":-7.360747,"eighty":10.081702,"marketCap":685943695},{"date":"2021-10-22","current":-4495.875323,"twenty":-18.531858,"median":-7.399285,"eighty":10.066019,"marketCap":646016821},{"date":"2021-10-29","current":-4540.333918,"twenty":-18.676955,"median":-7.433122,"eighty":10.050138,"marketCap":652405121},{"date":"2021-11-05","current":-4701.496322,"twenty":-18.759288,"median":-7.47636,"eighty":10.050138,"marketCap":675562708},{"date":"2021-11-12","current":-5407.276503,"twenty":-18.833125,"median":-7.553436,"eighty":10.050138,"marketCap":776976968},{"date":"2021-11-19","current":-4351.384888,"twenty":-18.921888,"median":-7.591974,"eighty":10.00614,"marketCap":625254846},{"date":"2021-11-26","current":-4318.040942,"twenty":-18.997487,"median":-7.630512,"eighty":9.902802,"marketCap":620463621},{"date":"2021-12-03","current":65.587739,"twenty":-19.081198,"median":-7.630512,"eighty":9.810049,"marketCap":484980272},{"date":"2021-12-10","current":67.64412,"twenty":-19.081198,"median":-7.630512,"eighty":9.810049,"marketCap":500185925},{"date":"2021-12-17","current":68.618196,"twenty":-19.081198,"median":-7.630512,"eighty":9.810049,"marketCap":507388602},{"date":"2021-12-23","current":68.077043,"twenty":-19.081198,"median":-7.630512,"eighty":9.810049,"marketCap":503387114},{"date":"2021-12-31","current":63.747819,"twenty":-19.081198,"median":-7.630512,"eighty":9.865738,"marketCap":471375215},{"date":"2022-01-07","current":59.093904,"twenty":-19.073366,"median":-7.630512,"eighty":9.962232,"marketCap":436962424},{"date":"2022-01-14","current":63.747819,"twenty":-19.073366,"median":-7.630512,"eighty":9.962232,"marketCap":471375215},{"date":"2022-01-21","current":53.03299,"twenty":-19.073366,"median":-7.630512,"eighty":9.976009,"marketCap":392145765},{"date":"2022-01-28","current":51.313694,"twenty":-19.073366,"median":-7.630512,"eighty":9.976009,"marketCap":379432648},{"date":"2022-02-04","current":57.700842,"twenty":-19.073366,"median":-7.630512,"eighty":9.976009,"marketCap":426661607},{"date":"2022-02-11","current":-31.40133,"twenty":-19.107061,"median":-7.66905,"eighty":9.957569,"marketCap":509120219},{"date":"2022-02-18","current":-28.093328,"twenty":-19.245361,"median":-7.707588,"eighty":9.957569,"marketCap":455486485},{"date":"2022-02-25","current":-28.43894,"twenty":-19.359564,"median":-7.743043,"eighty":9.957569,"marketCap":461090010},{"date":"2022-03-04","current":-25.970282,"twenty":-19.661782,"median":-7.803933,"eighty":9.957569,"marketCap":421064835},{"date":"2022-03-11","current":-25.427178,"twenty":-19.740387,"median":-7.844521,"eighty":9.957569,"marketCap":412259297},{"date":"2022-03-18","current":-26.315894,"twenty":-20.260869,"median":-7.993723,"eighty":9.957569,"marketCap":426668360},{"date":"2022-03-25","current":-25.081565,"twenty":-20.695892,"median":-8.05443,"eighty":9.957569,"marketCap":406655772},{"date":"2022-04-01","current":-23.945983,"twenty":-20.953065,"median":-8.131505,"eighty":9.957569,"marketCap":388244192},{"date":"2022-04-08","current":-21.477325,"twenty":-21.084006,"median":-8.170043,"eighty":9.957569,"marketCap":348219018},{"date":"2022-04-14","current":-73.812875,"twenty":-21.339069,"median":-8.18267,"eighty":9.957569,"marketCap":1196752717},{"date":"2022-04-22","current":-55.347313,"twenty":-21.845526,"median":-8.215032,"eighty":9.957569,"marketCap":897364412},{"date":"2022-04-29","current":-57.865344,"twenty":-22.256879,"median":-8.343464,"eighty":9.957569,"marketCap":938190090},{"date":"2022-05-06","current":-41.769694,"twenty":-22.487596,"median":-8.661402,"eighty":9.957569,"marketCap":677225952},{"date":"2022-05-13","current":-37.790924,"twenty":-22.789865,"median":-8.961609,"eighty":9.957569,"marketCap":1040957879},{"date":"2022-05-20","current":-38.895582,"twenty":-23.268524,"median":-9.028717,"eighty":9.957569,"marketCap":1071385878},{"date":"2022-05-27","current":-37.296735,"twenty":-23.866985,"median":-9.121319,"eighty":9.865369,"marketCap":1027345352},{"date":"2022-06-03","current":-42.035135,"twenty":-24.679148,"median":-9.19635,"eighty":9.773169,"marketCap":1157865456},{"date":"2022-06-10","current":-38.139763,"twenty":-25.09144,"median":-9.327119,"eighty":-3.441122,"marketCap":1050566720},{"date":"2022-06-17","current":-37.180455,"twenty":-25.654294,"median":-9.352825,"eighty":-3.505159,"marketCap":1024142405},{"date":"2022-06-24","current":-38.401393,"twenty":-26.200728,"median":-9.491728,"eighty":-3.531317,"marketCap":1057773352},{"date":"2022-07-01","current":-32.558334,"twenty":-26.760253,"median":-9.538029,"eighty":-3.547117,"marketCap":896825249},{"date":"2022-07-08","current":-38.721162,"twenty":-27.678594,"median":-9.630631,"eighty":-3.618217,"marketCap":1066581457},{"date":"2022-07-15","current":-50.087509,"twenty":-29.643645,"median":-9.769535,"eighty":-3.662107,"marketCap":1379669558},{"date":"2022-07-22","current":-40.959548,"twenty":-30.976721,"median":-9.854517,"eighty":-3.744762,"marketCap":1128238193},{"date":"2022-07-29","current":-35.174629,"twenty":-31.880795,"median":-9.954739,"eighty":-3.826065,"marketCap":968891564},{"date":"2022-08-05","current":-36.657196,"twenty":-32.752419,"median":-9.96714,"eighty":-3.90479,"marketCap":1009729142},{"date":"2022-08-12","current":-32.503044,"twenty":-32.903846,"median":-10.116562,"eighty":-3.911441,"marketCap":1529199703},{"date":"2022-08-19","current":-29.760387,"twenty":-33.169357,"median":-10.192386,"eighty":-3.974715,"marketCap":1400163460},{"date":"2022-08-26","current":-28.397576,"twenty":-33.169357,"median":-10.248698,"eighty":-4.026483,"marketCap":1336046072},{"date":"2022-09-02","current":-25.212005,"twenty":-33.169357,"median":-10.278847,"eighty":-4.054936,"marketCap":1186171678},{"date":"2022-09-09","current":-26.52371,"twenty":-33.169357,"median":-10.371449,"eighty":-4.084004,"marketCap":1247884663},{"date":"2022-09-16","current":-24.326178,"twenty":-33.169357,"median":-10.41775,"eighty":-4.112765,"marketCap":1144495375},{"date":"2022-09-23","current":-17.409911,"twenty":-33.169357,"median":-10.487202,"eighty":-4.141526,"marketCap":819099631},{"date":"2022-09-30","current":-19.624479,"twenty":-33.169357,"median":-10.541837,"eighty":-4.216303,"marketCap":923290387},{"date":"2022-10-07","current":-18.857898,"twenty":-33.169357,"median":-10.602955,"eighty":-4.256568,"marketCap":887224356},{"date":"2022-10-14","current":-18.50016,"twenty":-33.169357,"median":-10.702781,"eighty":-4.285329,"marketCap":870393542},{"date":"2022-10-21","current":-19.045285,"twenty":-33.169357,"median":-10.863725,"eighty":-4.340179,"marketCap":896040497},{"date":"2022-10-28","current":-20.799904,"twenty":-33.169357,"median":-11.093371,"eighty":-4.373703,"marketCap":978591634},{"date":"2022-11-04","current":-17.631368,"twenty":-33.169357,"median":-11.346557,"eighty":-4.40709,"marketCap":829518707},{"date":"2022-11-11","current":-11.226156,"twenty":-33.169357,"median":-11.829389,"eighty":-4.440477,"marketCap":528166983},{"date":"2022-11-18","current":-10.221083,"twenty":-33.169357,"median":-11.829389,"eighty":-4.467475,"marketCap":480880410},{"date":"2022-11-25","current":-9.556713,"twenty":-33.169357,"median":-11.829389,"eighty":-4.527283,"marketCap":449623183},{"date":"2022-12-02","current":-9.369326,"twenty":-33.169357,"median":-11.829389,"eighty":-4.572935,"marketCap":440807042},{"date":"2022-12-09","current":-5.264138,"twenty":-33.169357,"median":-11.829389,"eighty":-4.607413,"marketCap":441008510},{"date":"2022-12-16","current":-4.802202,"twenty":-33.169357,"median":-11.829389,"eighty":-4.627445,"marketCap":402309408},{"date":"2022-12-23","current":-4.859944,"twenty":-33.169357,"median":-11.829389,"eighty":-4.645808,"marketCap":407146796},{"date":"2022-12-30","current":-5.081288,"twenty":-33.169357,"median":-11.829389,"eighty":-4.674187,"marketCap":425690115},{"date":"2023-01-06","current":-5.206396,"twenty":-33.169357,"median":-11.346557,"eighty":-4.674187,"marketCap":436171122},{"date":"2023-01-13","current":-6.024406,"twenty":-33.169357,"median":-11.149682,"eighty":-4.674187,"marketCap":504700781},{"date":"2023-01-20","current":-6.168761,"twenty":-33.169357,"median":-11.093371,"eighty":-4.674187,"marketCap":516794250},{"date":"2023-01-27","current":-5.677955,"twenty":-33.169357,"median":-11.093371,"eighty":-4.674187,"marketCap":475676455},{"date":"2023-02-03","current":-5.543224,"twenty":-33.169357,"median":-11.093371,"eighty":-4.674187,"marketCap":464389217},{"date":"2023-02-10","current":-2.930076,"twenty":-33.169357,"median":-11.037059,"eighty":-4.67401,"marketCap":334726628},{"date":"2023-02-17","current":-3.240735,"twenty":-33.169357,"median":-11.037059,"eighty":-4.636071,"marketCap":370215717},{"date":"2023-02-24","current":-2.923016,"twenty":-33.169357,"median":-11.037059,"eighty":-4.607413,"marketCap":333920058},{"date":"2023-03-03","current":-1.708623,"twenty":-33.169357,"median":-11.037059,"eighty":-4.601059,"marketCap":195189985},{"date":"2023-03-10","current":-1.539173,"twenty":-33.169357,"median":-11.037059,"eighty":-4.558784,"marketCap":175832301},{"date":"2023-03-17","current":-1.129668,"twenty":-33.169357,"median":-10.980748,"eighty":-4.496314,"marketCap":129051230},{"date":"2023-03-24","current":-0.974339,"twenty":-33.169357,"median":-10.69919,"eighty":-4.450926,"marketCap":111306686},{"date":"2023-03-31","current":-0.819009,"twenty":-33.130781,"median":-10.690111,"eighty":-4.420445,"marketCap":93562142},{"date":"2023-04-06","current":-0.790768,"twenty":-33.130781,"median":-10.690111,"eighty":-4.395037,"marketCap":90335861},{"date":"2023-04-14","current":-0.805942,"twenty":-33.169357,"median":-10.69919,"eighty":-4.360106,"marketCap":92069388},{"date":"2023-04-21","current":-0.921077,"twenty":-33.169357,"median":-10.69919,"eighty":-4.314089,"marketCap":105222158},{"date":"2023-04-28","current":-0.974806,"twenty":-33.169357,"median":-10.681032,"eighty":-4.280614,"marketCap":111360117},{"date":"2023-05-05","current":-0.983162,"twenty":-33.169357,"median":-10.544751,"eighty":-4.256568,"marketCap":112314649},{"date":"2023-05-12","current":-0.783397,"twenty":-33.169357,"median":-10.487202,"eighty":-4.170286,"marketCap":108777180},{"date":"2023-05-19","current":-0.726216,"twenty":-33.169357,"median":-10.487202,"eighty":-4.140913,"marketCap":100837507},{"date":"2023-05-26","current":-0.661949,"twenty":-33.169357,"median":-10.487202,"eighty":-4.112765,"marketCap":91913833},{"date":"2023-06-02","current":-0.627181,"twenty":-33.169357,"median":-10.487202,"eighty":-4.0725,"marketCap":87086126},{"date":"2023-06-09","current":-0.841897,"twenty":-33.169357,"median":-10.487202,"eighty":-4.038229,"marketCap":116900118},{"date":"2023-06-16","current":-0.841897,"twenty":-33.169357,"median":-10.42788,"eighty":-4.017478,"marketCap":116900118},{"date":"2023-06-23","current":-0.751923,"twenty":-33.207932,"median":-10.457541,"eighty":-3.940202,"marketCap":104406976},{"date":"2023-06-30","current":-0.75835,"twenty":-33.246508,"median":-10.487202,"eighty":-3.911441,"marketCap":105299343},{"date":"2023-07-07","current":-0.713363,"twenty":-33.246508,"median":-10.487202,"eighty":-3.90479,"marketCap":99052772},{"date":"2023-07-14","current":-0.809763,"twenty":-33.246508,"median":-10.487202,"eighty":-3.83172,"marketCap":112438282},{"date":"2023-07-21","current":-0.85475,"twenty":-33.246508,"median":-10.487202,"eighty":-3.751388,"marketCap":118684853},{"date":"2023-07-28","current":-0.764776,"twenty":-33.246508,"median":-10.487202,"eighty":-3.667339,"marketCap":106191711},{"date":"2023-08-04","current":-0.751923,"twenty":-33.246508,"median":-10.487202,"eighty":-3.626258,"marketCap":104406976},{"date":"2023-08-11","current":-0.881502,"twenty":-33.246508,"median":-10.374399,"eighty":-3.536758,"marketCap":97268037},{"date":"2023-08-18","current":-0.842722,"twenty":-33.246508,"median":-10.374399,"eighty":-3.531317,"marketCap":92988852},{"date":"2023-08-25","current":-0.842722,"twenty":-33.246508,"median":-10.374399,"eighty":-3.505159,"marketCap":92988852},{"date":"2023-09-01","current":-0.850903,"twenty":-33.246508,"median":-10.374399,"eighty":-3.410677,"marketCap":93891656},{"date":"2023-09-08","current":-0.850903,"twenty":-33.285083,"median":-10.459575,"eighty":-3.16307,"marketCap":93891656},{"date":"2023-09-15","current":-0.826358,"twenty":-33.285083,"median":-10.459575,"eighty":-2.923016,"marketCap":91183243},{"date":"2023-09-21","current":-0.750677,"twenty":-33.290827,"median":-10.544751,"eighty":-2.825582,"marketCap":82832302},{"date":"2023-09-28","current":-0.638178,"twenty":-33.308061,"median":-10.953594,"eighty":-2.693552,"marketCap":70418742},{"date":"2023-10-06","current":-0.62435,"twenty":-33.350645,"median":-11.873491,"eighty":-1.700151,"marketCap":68893003},{"date":"2023-10-13","current":-0.69995,"twenty":-33.350645,"median":-11.873491,"eighty":-1.450211,"marketCap":77234915},{"date":"2023-10-20","current":-0.708623,"twenty":-33.350645,"median":-11.873491,"eighty":-1.126844,"marketCap":78191888},{"date":"2023-10-23","current":-0.661823,"twenty":-33.350645,"median":-11.873491,"eighty":-1.106471,"marketCap":73027847},{"date":"2023-11-02","current":-0.711486,"twenty":-33.414144,"median":-12.952649,"eighty":-1.051286,"marketCap":78507869},{"date":"2023-11-10","current":-0.743477,"twenty":-33.418263,"median":-12.989025,"eighty":-0.983162,"marketCap":82037834},{"date":"2023-11-17","current":-0.818095,"twenty":-33.422382,"median":-13.016085,"eighty":-0.974432,"marketCap":90271410},{"date":"2023-11-24","current":-0.739416,"twenty":-33.426501,"median":-13.043146,"eighty":-0.932721,"marketCap":91183243},{"date":"2023-12-01","current":-0.699224,"twenty":-33.426501,"median":-13.043146,"eighty":-0.917855,"marketCap":86226847},{"date":"2023-12-08","current":-0.834589,"twenty":-33.422382,"median":-13.016085,"eighty":-0.885267,"marketCap":102919700},{"date":"2023-12-15","current":-0.757824,"twenty":-33.422382,"median":-13.016085,"eighty":-0.875449,"marketCap":70545026},{"date":"2023-12-22","current":-1.00858,"twenty":-33.422382,"median":-13.016085,"eighty":-0.875449,"marketCap":93887663},{"date":"2023-12-29","current":-1.136713,"twenty":-33.426501,"median":-13.043146,"eighty":-0.875449,"marketCap":105815442},{"date":"2024-01-05","current":-0.972763,"twenty":-33.427287,"median":-13.053941,"eighty":-0.875042,"marketCap":90553465},{"date":"2024-01-12","current":-0.656102,"twenty":-33.427287,"median":-13.053941,"eighty":-0.859085,"marketCap":61075808},{"date":"2024-01-19","current":-0.621933,"twenty":-33.428074,"median":-13.064736,"eighty":-0.85475,"marketCap":57895067},{"date":"2024-01-26","current":-0.659848,"twenty":-33.427287,"median":-13.053941,"eighty":-0.850387,"marketCap":61424574},{"date":"2024-02-02","current":-0.770519,"twenty":-33.427287,"median":-13.053941,"eighty":-0.842722,"marketCap":71726781},{"date":"2024-02-09","current":-0.646449,"twenty":-33.427287,"median":-13.053941,"eighty":-0.841897,"marketCap":60177305},{"date":"2024-02-16","current":-0.660445,"twenty":-33.427287,"median":-13.053941,"eighty":-0.834579,"marketCap":61480098},{"date":"2024-02-23","current":-0.87273,"twenty":-33.427287,"median":-13.053941,"eighty":-0.828506,"marketCap":81241558},{"date":"2024-03-01","current":-0.951512,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":88575255},{"date":"2024-03-08","current":-0.962362,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":89585285},{"date":"2024-03-15","current":-0.94365,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":87843349},{"date":"2024-03-22","current":-0.90245,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":84008162},{"date":"2024-03-28","current":-1.01677,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":94650074},{"date":"2024-04-05","current":-1.937132,"twenty":-33.427287,"median":-13.053941,"eighty":-0.828506,"marketCap":121496384},{"date":"2024-04-12","current":-4.177671,"twenty":-33.427287,"median":-13.053941,"eighty":-0.828506,"marketCap":262022322},{"date":"2024-04-19","current":-3.31413,"twenty":-33.427287,"median":-13.053941,"eighty":-0.828506,"marketCap":207861284},{"date":"2024-04-26","current":-2.824012,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":177121235},{"date":"2024-05-03","current":-3.827587,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":240065145},{"date":"2024-05-10","current":-5.147825,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":200542224},{"date":"2024-05-17","current":-5.147825,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":200542224},{"date":"2024-05-24","current":-4.772161,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":185907578},{"date":"2024-05-31","current":-3.631351,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":141465420},{"date":"2024-06-07","current":-3.462259,"twenty":-33.426501,"median":-13.043146,"eighty":-0.829043,"marketCap":134878143},{"date":"2024-06-14","current":-3.150753,"twenty":-33.427287,"median":-13.053941,"eighty":-0.828506,"marketCap":122742916},{"date":"2024-06-21","current":-2.930933,"twenty":-33.428074,"median":-13.064736,"eighty":-0.827969,"marketCap":114179457},{"date":"2024-06-28","current":-3.006085,"twenty":-33.430433,"median":-13.386405,"eighty":-0.826358,"marketCap":117107136},{"date":"2024-07-05","current":-3.437083,"twenty":-33.430433,"median":-13.386405,"eighty":-0.826358,"marketCap":133897371},{"date":"2024-07-12","current":-3.499835,"twenty":-33.430433,"median":-13.386405,"eighty":-0.826358,"marketCap":136341983},{"date":"2024-07-15","current":-3.558829,"twenty":-33.430433,"median":-13.386405,"eighty":-0.826358,"marketCap":138640210},{"date":"2024-08-02","current":-3.340888,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":130149943},{"date":"2024-08-09","current":-3.170491,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":118585613},{"date":"2024-08-16","current":-3.287511,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":122962492},{"date":"2024-08-23","current":-3.266377,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":122172019},{"date":"2024-08-30","current":-3.189668,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":119302894},{"date":"2024-09-06","current":-3.428013,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":128217675},{"date":"2024-09-13","current":-3.267551,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":122215934},{"date":"2024-09-20","current":-3.135659,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":117282796},{"date":"2024-09-27","current":-3.037034,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":113593921},{"date":"2024-10-04","current":-2.950932,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":110373475},{"date":"2024-10-11","current":-3.229588,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":120796010},{"date":"2024-10-18","current":-3.383396,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":126548898},{"date":"2024-10-25","current":-3.304731,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":123606582},{"date":"2024-10-31","current":-2.997114,"twenty":-33.627472,"median":-14.796803,"eighty":-0.819009,"marketCap":112100805},{"date":"2024-11-08","current":-2.870701,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":107372605},{"date":"2024-11-15","current":-2.461328,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":92060847},{"date":"2024-11-22","current":-2.457414,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":91914463},{"date":"2024-11-29","current":-2.769728,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":103595900},{"date":"2024-12-06","current":-2.817866,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":105396422},{"date":"2024-12-13","current":-2.914926,"twenty":-33.673771,"median":-14.833919,"eighty":-0.819009,"marketCap":109026743},{"date":"2024-12-20","current":-2.435768,"twenty":-33.673771,"median":-14.065336,"eighty":-0.819009,"marketCap":92075485},{"date":"2024-12-27","current":-2.651075,"twenty":-33.673771,"median":-13.064736,"eighty":-0.819009,"marketCap":100214431},{"date":"2025-01-03","current":-2.524059,"twenty":-33.673771,"median":-11.549823,"eighty":-0.819009,"marketCap":95413039},{"date":"2025-01-10","current":-2.811395,"twenty":-33.720071,"median":-10.221083,"eighty":-0.819009,"marketCap":106274725},{"date":"2025-01-17","current":-3.267181,"twenty":-33.720071,"median":-9.386361,"eighty":-0.819009,"marketCap":123504113},{"date":"2025-01-24","current":-4.956729,"twenty":-33.720071,"median":-9.164904,"eighty":-0.819009,"marketCap":187371417},{"date":"2025-01-31","current":-2.247954,"twenty":-33.720071,"median":-6.024406,"eighty":-0.819009,"marketCap":84975865},{"date":"2025-02-07","current":-2.250277,"twenty":-33.720071,"median":-5.899299,"eighty":-0.819009,"marketCap":85063695},{"date":"2025-02-14","current":-1.999562,"twenty":-33.720071,"median":-5.677955,"eighty":-0.819009,"marketCap":76924749},{"date":"2025-02-21","current":-2.243848,"twenty":-33.720071,"median":-5.543224,"eighty":-0.819009,"marketCap":86322597},{"date":"2025-02-28","current":-1.964556,"twenty":-33.720071,"median":-5.475858,"eighty":-0.819009,"marketCap":75578017},{"date":"2025-03-07","current":-2.009836,"twenty":-33.771778,"median":-5.348038,"eighty":-0.818842,"marketCap":77319986},{"date":"2025-03-14","current":-1.716465,"twenty":-33.771778,"median":-5.206396,"eighty":-0.818842,"marketCap":66033786},{"date":"2025-03-21","current":-1.920798,"twenty":-33.771778,"median":-5.128992,"eighty":-0.818842,"marketCap":73894602},{"date":"2025-03-28","current":-2.083274,"twenty":-33.771778,"median":-5.015347,"eighty":-0.818842,"marketCap":80145196},{"date":"2025-04-04","current":-2.212266,"twenty":-33.771778,"median":-4.941745,"eighty":-0.818842,"marketCap":85107611},{"date":"2025-04-11","current":-1.995757,"twenty":-33.720071,"median":-4.859944,"eighty":-0.819009,"marketCap":76778366},{"date":"2025-04-17","current":-1.998421,"twenty":-33.720071,"median":-4.744461,"eighty":-0.819009,"marketCap":76880834},{"date":"2025-04-25","current":-2.089362,"twenty":-33.771778,"median":-4.199318,"eighty":-0.818842,"marketCap":80379410},{"date":"2025-05-02","current":-1.995757,"twenty":-33.771778,"median":-3.815917,"eighty":-0.818842,"marketCap":76778366},{"date":"2025-05-09","current":-2.102737,"twenty":-33.771778,"median":-3.767394,"eighty":-0.818842,"marketCap":76427044},{"date":"2025-05-16","current":-2.072539,"twenty":-33.771778,"median":-3.589676,"eighty":-0.818842,"marketCap":75329476},{"date":"2025-05-23","current":-1.975345,"twenty":-33.771778,"median":-3.562253,"eighty":-0.818842,"marketCap":71796804},{"date":"2025-05-30","current":-2.053584,"twenty":-33.771778,"median":-3.500126,"eighty":-0.818842,"marketCap":74640532},{"date":"2025-06-06","current":-2.431876,"twenty":-33.771778,"median":-3.437083,"eighty":-0.818842,"marketCap":88390103},{"date":"2025-06-13","current":-2.633524,"twenty":-33.771778,"median":-3.407465,"eighty":-0.818842,"marketCap":95719299},{"date":"2025-06-20","current":-2.435909,"twenty":-33.823484,"median":-3.383396,"eighty":-0.818676,"marketCap":88536687},{"date":"2025-06-27","current":-2.6428,"twenty":-33.823484,"median":-3.339761,"eighty":-0.818676,"marketCap":96056442},{"date":"2025-07-03","current":-2.446395,"twenty":-33.823484,"median":-3.310452,"eighty":-0.818676,"marketCap":88917805},{"date":"2025-07-11","current":-2.352024,"twenty":-33.823484,"median":-3.287902,"eighty":-0.818676,"marketCap":85487742},{"date":"2025-07-18","current":-2.475432,"twenty":-33.823484,"median":-3.266377,"eighty":-0.818676,"marketCap":89973210},{"date":"2025-07-25","current":-2.419777,"twenty":-33.823484,"median":-3.240735,"eighty":-0.818676,"marketCap":87950352},{"date":"2025-08-01","current":-1.954777,"twenty":-33.823484,"median":-3.205433,"eighty":-0.818676,"marketCap":71049226},{"date":"2025-08-08","current":-1.504698,"twenty":-33.823484,"median":-3.179492,"eighty":-0.818676,"marketCap":54690460},{"date":"2025-08-15","current":-1.661641,"twenty":-33.823484,"median":-3.154135,"eighty":-0.818676,"marketCap":54352954},{"date":"2025-08-22","current":-1.58998,"twenty":-33.823484,"median":-3.135659,"eighty":-0.818676,"marketCap":52008891},{"date":"2025-08-29","current":-1.509361,"twenty":-33.823484,"median":-3.120708,"eighty":-0.818676,"marketCap":49371821},{"date":"2025-09-05","current":-1.478009,"twenty":-33.875191,"median":-3.07278,"eighty":-0.818509,"marketCap":48346293},{"date":"2025-09-12","current":-1.594459,"twenty":-33.823484,"median":-3.047795,"eighty":-0.818676,"marketCap":52155395},{"date":"2025-09-19","current":-1.598937,"twenty":-33.823484,"median":-3.027477,"eighty":-0.818676,"marketCap":52301899},{"date":"2025-09-26","current":-1.607895,"twenty":-33.823484,"median":-3.009638,"eighty":-0.818676,"marketCap":52594907},{"date":"2025-10-03","current":-1.728823,"twenty":-33.823484,"median":-2.975715,"eighty":-0.818676,"marketCap":56550513},{"date":"2025-10-10","current":-1.916933,"twenty":-33.823484,"median":-2.949758,"eighty":-0.818676,"marketCap":62703677},{"date":"2025-10-17","current":-1.867666,"twenty":-33.823484,"median":-2.9175,"eighty":-0.818676,"marketCap":61092134},{"date":"2025-10-24","current":-1.66612,"twenty":-33.823484,"median":-2.899271,"eighty":-0.818676,"marketCap":54499458},{"date":"2025-10-31","current":-1.348124,"twenty":-33.823484,"median":-2.875006,"eighty":-0.818676,"marketCap":44097679},{"date":"2025-11-07","current":-1.128662,"twenty":-33.823484,"median":-2.857003,"eighty":-0.818676,"marketCap":36918987},{"date":"2025-11-14","current":-1.23161,"twenty":-33.823484,"median":-2.828433,"eighty":-0.818676,"marketCap":40286483},{"date":"2025-11-21","current":-1.09422,"twenty":-33.823484,"median":-2.811395,"eighty":-0.818676,"marketCap":35792374},{"date":"2025-11-28","current":-1.21689,"twenty":-33.823484,"median":-2.792398,"eighty":-0.818676,"marketCap":39804972},{"date":"2025-12-05","current":-1.187449,"twenty":-33.823484,"median":-2.737244,"eighty":-0.818676,"marketCap":38841948},{"date":"2025-12-12","current":-1.256145,"twenty":-33.823484,"median":-2.696842,"eighty":-0.818676,"marketCap":41089003},{"date":"2025-12-19","current":-1.596114,"twenty":-33.428074,"median":-2.651075,"eighty":-0.818676,"marketCap":36273723},{"date":"2025-12-26","current":-1.652613,"twenty":-33.350645,"median":-2.633524,"eighty":-0.818676,"marketCap":37557748},{"date":"2026-01-02","current":-1.511364,"twenty":-33.296572,"median":-2.57913,"eighty":-0.818676,"marketCap":34347684},{"date":"2026-01-09","current":-1.631426,"twenty":-32.903846,"median":-2.500437,"eighty":-0.818676,"marketCap":37076239},{"date":"2026-01-16","current":-1.709113,"twenty":-32.103103,"median":-2.461328,"eighty":-0.818676,"marketCap":38841774},{"date":"2026-01-23","current":-1.899799,"twenty":-30.976721,"median":-2.454675,"eighty":-0.818676,"marketCap":43175360},{"date":"2026-01-30","current":-1.843299,"twenty":-29.844035,"median":-2.435909,"eighty":-0.818676,"marketCap":41891335},{"date":"2026-02-06","current":-1.581989,"twenty":-28.649626,"median":-2.431876,"eighty":-0.818676,"marketCap":35952716},{"date":"2026-02-13","current":-1.881011,"twenty":-28.414122,"median":-2.419777,"eighty":-0.824862,"marketCap":35952716},{"date":"2026-02-20","current":-2.090945,"twenty":-28.414122,"median":-2.419777,"eighty":-0.834569,"marketCap":39965296},{"date":"2026-02-27","current":-2.2337,"twenty":-28.414122,"median":-2.419777,"eighty":-0.841897,"marketCap":42693851},{"date":"2026-03-06","current":-2.149726,"twenty":-28.414122,"median":-2.419777,"eighty":-0.842722,"marketCap":41088819},{"date":"2026-03-13","current":-2.065753,"twenty":-28.414122,"median":-2.419777,"eighty":-0.849871,"marketCap":39483787},{"date":"2026-03-20","current":-1.922997,"twenty":-28.414122,"median":-2.419777,"eighty":-0.85475,"marketCap":36755232},{"date":"2026-03-27","current":-1.872613,"twenty":-28.414122,"median":-2.419777,"eighty":-0.862743,"marketCap":35792213},{"date":"2026-04-02","current":-1.906203,"twenty":-28.414122,"median":-2.419777,"eighty":-0.873141,"marketCap":36434226},{"date":"2026-04-10","current":-2.040561,"twenty":-28.414122,"median":-2.419777,"eighty":-0.881138,"marketCap":39002277},{"date":"2026-04-17","current":-2.07415,"twenty":-28.414122,"median":-2.419777,"eighty":-0.897014,"marketCap":39644290},{"date":"2026-04-24","current":-1.939792,"twenty":-28.414122,"median":-2.419777,"eighty":-0.917256,"marketCap":37076239},{"date":"2026-05-01","current":-1.889408,"twenty":-28.414122,"median":-2.419777,"eighty":-0.930292,"marketCap":36113220},{"date":"2026-05-08","current":-1.9146,"twenty":-28.414122,"median":-2.419777,"eighty":-0.944782,"marketCap":36594729},{"date":"2026-05-15","current":-2.40415,"twenty":-27.914631,"median":-2.415456,"eighty":-0.950504,"marketCap":33545168},{"date":"2026-05-22","current":-2.553691,"twenty":-27.054326,"median":-2.415456,"eighty":-0.950504,"marketCap":35631710},{"date":"2026-05-29","current":-2.668722,"twenty":-26.606388,"median":-2.411974,"eighty":-0.950001,"marketCap":37236742},{"date":"2026-06-05","current":-4.865816,"twenty":-26.220089,"median":-2.415456,"eighty":-0.950504,"marketCap":67892853},{"date":"2026-06-12","current":-3.750015,"twenty":-25.990031,"median":-2.415456,"eighty":-0.950504,"marketCap":52324043},{"date":"2026-06-18","current":-3.43943,"twenty":-25.571965,"median":-2.415456,"eighty":-0.950504,"marketCap":47990456},{"date":"2026-06-26","current":-3.381915,"twenty":-25.293774,"median":-2.411974,"eighty":-0.950001,"marketCap":47187940},{"date":"2026-07-02","current":-3.634983,"twenty":-25.002568,"median":-2.411974,"eighty":-0.950001,"marketCap":50719011},{"date":"2026-07-10","current":-3.232375,"twenty":-24.554879,"median":-2.411974,"eighty":-0.950001,"marketCap":45101399},{"date":"2026-07-17","current":-2.703231,"twenty":-23.738615,"median":-2.411974,"eighty":-0.950001,"marketCap":37718252},{"date":"2026-07-24","current":-2.657219,"twenty":-21.643253,"median":-2.411974,"eighty":-0.950001,"marketCap":37076239},{"date":"2026-07-31","current":-2.553691,"twenty":-20.851009,"median":-2.408493,"eighty":-0.949497,"marketCap":35631710},{"date":"2026-08-07","current":-2.657219,"twenty":-20.247966,"median":-2.408493,"eighty":-0.949497,"marketCap":37076239},{"date":"2026-08-14","current":-3.382862,"twenty":-19.621072,"median":-2.408493,"eighty":-0.949497,"marketCap":46035864},{"date":"2026-08-21","current":-3.232513,"twenty":-19.379174,"median":-2.408493,"eighty":-0.949497,"marketCap":43989825},{"date":"2026-08-28","current":-3.432979,"twenty":-18.939667,"median":-2.408493,"eighty":-0.949497,"marketCap":46717876},{"date":"2026-09-04","current":-3.320217,"twenty":-18.541045,"median":-2.408493,"eighty":-0.949497,"marketCap":45183348},{"date":"2026-09-11","current":-3.13228,"twenty":-18.156051,"median":-2.408493,"eighty":-0.949497,"marketCap":42625800},{"date":"2026-09-18","current":-2.99446,"twenty":-11.117131,"median":-2.408493,"eighty":-0.949497,"marketCap":40750264},{"date":"2026-09-25","current":-3.144809,"twenty":-10.016661,"median":-2.408493,"eighty":-0.949497,"marketCap":42796303},{"date":"2026-10-02","current":-3.182396,"twenty":-9.362512,"median":-2.408493,"eighty":-0.949497,"marketCap":43307812},{"date":"2026-10-06","current":-3.194925,"twenty":-9.219417,"median":-2.408493,"eighty":-0.949497,"marketCap":43478316}],"updateTime":1791412447546},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VERU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648638106","title":"Veru - to Offer and Sell up to $21.8 Mln of Common Stock Under Sales Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648638106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648638106?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:09","pubTimestamp":1783022989,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340XJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","VERU","BK4183","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648638450","title":"Veru Enters At-the-market Equity Sales Agreement for up to $21.8 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648638450","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648638450?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:09","pubTimestamp":1783022975,"startTime":"0","endTime":"0","summary":"Veru enters at-the-market equity sales agreement for up to $21.8 million stock offeringVeru entered an at-the-market sales agreement to issue and sell up to USD 21.8 million of common stock.Oppenheime","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL7PCVZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4584","BK4007","VERU","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169473","title":"Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169473","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169473?lang=en_us&edition=fundamental","pubTime":"2026-06-05 01:09","pubTimestamp":1780592947,"startTime":"0","endTime":"0","summary":"Veru  said Thursday in a regulatory filing that it entered a clinical supply agreement with Novo Nordisk  to support its phase 2b PLATEAU study evaluating enobosarm in combination with Novo's Wegovy in older adults with obesity undergoing weight loss treatment.Under the agreement, Novo Nordisk will provide Wegovy free of charge for the study, while Veru will sponsor and conduct the trial and share clinical study updates and insights related to obesity and weight management research, the filing shows.Veru said it retains global development and commercialization rights to enobosarm, while Novo Nordisk received a right of first negotiation if Veru seeks to develop, commercialize or license enobosarm in combination with Novo Nordisk GLP-1 products in the future.Shares of Veru rose 155% in Thursday trading.Price: 5.52, Change: +3.27, Percent Change: +145.47","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","NVOH","NVOX","BK4588","IE00BKVL7J92.USD","VERU","NVO","BK4584","BK4007","BK4557","BK4585","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641434169","title":"Veru pact with Novo ‘significant event,’ says Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2641434169","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641434169?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:45","pubTimestamp":1780591529,"startTime":"0","endTime":"0","summary":"Canaccord keeps a Buy rating on Veru (VERU) with a $25 price target after the company disclosed a supply agreement with Novo Nordisk (NVO) for Wego...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veru-pact-with-novo-significant-event-says-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veru-pact-with-novo-significant-event-says-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERU","BK4532","LU1093756325.SGD","BK4599","BK4183","BK4585","LU1093756168.USD","NVOX","BK4584","IE00BKVL7J92.USD","BK4588","IE00BZ1G4Q59.USD","BK4007","NVO","NVOH","BK4557","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641602169","title":"Veru Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2641602169","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641602169?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:44","pubTimestamp":1780591440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERU/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 04, 2026 12:44 ET (16:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4584","BK4557","BK4007","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641169651","title":"Veru announces clinical supply agreement with Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2641169651","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641169651?lang=en_us&edition=fundamental","pubTime":"2026-06-05 00:40","pubTimestamp":1780591226,"startTime":"0","endTime":"0","summary":"In a regulatory filing, Veru (VERU) announced that on June 2, the company entered into a clinical supply agreement with Novo Nordisk A/S (NVO) in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veru-announces-clinical-supply-agreement-with-novo-nordisk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veru-announces-clinical-supply-agreement-with-novo-nordisk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU0154236417.USD","BK4183","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756168.USD","NVO","NVOH","BK4007","BK4584","NVOX","VERU","LU1093756325.SGD","BK4532","IE00BZ1G4Q59.USD","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157267","title":"Veru enters clinical supply deal with Novo Nordisk for enobosarm-Wegovy obesity trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157267","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640157267?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:33","pubTimestamp":1780576406,"startTime":"0","endTime":"0","summary":"Veru entered a clinical supply agreement with Novo Nordisk on June 2, 2026 to support its Phase 2b PLATEAU obesity study.Novo Nordisk will provide Wegovy at no charge for use in the trial combining Wegovy with enobosarm in older adults.Veru will sponsor and run the study, providing Novo Nordisk trial-design and clinical-conduct insights, including protocol and safety updates.The deal grants Novo Nordisk a right of first negotiation on any future enobosarm combination with its GLP-1 products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veru Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commissio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL3s2DJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4584","BK4007","BK4183","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915717","title":"Veru - Enters Clinical Supply Agreement With Novo Nordisk for Phase 2B Plateau Study - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915717","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640915717?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:32","pubTimestamp":1780576320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nFWN42C01Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4007","BK4183","BK4584","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157437","title":"Veru - to Provide Novo Nordisk With Insights and Updates on Obesity Trial Design - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157437","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640157437?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:32","pubTimestamp":1780576320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nFWN42C01Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4584","BK4007","VERU","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157419","title":"Veru - Grants Novo Nordisk Right of First Negotiation for Enobosarm in Combination  With Any Novo's Glp-1 Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157419","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640157419?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:32","pubTimestamp":1780576320,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nFWN42C01Y:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","VERU","BK4183","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640965543","title":"Soccer-FIFA rolls out global initiative to boost female player health and performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2640965543","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640965543?lang=en_us&edition=fundamental","pubTime":"2026-06-02 00:36","pubTimestamp":1780331810,"startTime":"0","endTime":"0","summary":"Soccer-FIFA rolls out global initiative to boost female player health and performanceBy Lori EwingMANCHESTER, England, June 1 (Reuters) - FIFA is ramping up efforts to close one of sport's most persis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL8N4291GX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VERU","BK4183","BK4557","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635108412","title":"Veru : Oppenheimer Cuts Target Price to $24 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2635108412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635108412?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:23","pubTimestamp":1778847800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nAZN4SWKBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VERU","BK4183","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635964757","title":"Veru Inc. Earnings Call Highlights Clinical Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2635964757","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635964757?lang=en_us&edition=fundamental","pubTime":"2026-05-14 08:09","pubTimestamp":1778717351,"startTime":"0","endTime":"0","summary":"Veru Inc (($VERU)) has held its Q2 earnings call. Read on for the main highlights of the call. Veru Inc.’s latest earnings call struck a cautiously...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veru-inc-earnings-call-highlights-clinical-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veru-inc-earnings-call-highlights-clinical-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635804127","title":"Veru Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635804127","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635804127?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:32","pubTimestamp":1778679146,"startTime":"0","endTime":"0","summary":"Veru Inc reports results for the quarter ended March 31 - Earnings SummaryVeru Inc VERU.OQ reported a quarterly adjusted loss of 12 cents per share for the quarter ended March 31, higher than the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL8N41Q1TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","BK4183","VERU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783789","title":"Veru Q2 net loss narrows as expenses decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783789","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783789?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:39","pubTimestamp":1778668748,"startTime":"0","endTime":"0","summary":"Veru Q2 net loss narrows as expenses declineOverviewUS biopharma firm's fiscal Q2 net loss narrowed year-over-yearResearch and development and administrative expenses both declined from prior yearOutl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL1N41Q0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","VERU","BK4007","BK4584","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635831537","title":"Veru Q2 Net Income USD -2.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635831537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635831537?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:31","pubTimestamp":1778668290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLX255D06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERU","BK4584","BK4183","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635178312","title":"Veru FY26 Q2 net loss narrows to $2.74 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635178312","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635178312?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:31","pubTimestamp":1778668282,"startTime":"0","endTime":"0","summary":"Veru posted fiscal 2026 Q2 net loss of $2.7 million, or $0.12 per share, narrowing from $7.9 million, or $0.54 per share, a year earlier.Operating loss improved to $7.2 million from $8.1 million, while R&D expense fell to $3.1 million from $3.9 million.G&A expense dropped to $4.1 million from $5.2 million; cash, cash equivalents and restricted cash rose to $27.6 million at March 31 from $15.8 million at Sept. 30.Phase 2b PLATEAU trial of enobosarm 3 mg with semaglutide in about 200 older patients with obesity was actively enrolling, with interim DXA data expected in Q1 2027 and final topline results expected in Q4 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLnS31H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","VERU","BK4584","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","BK4183","BK4007","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","IE00BN0W2V16.EUR","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783940","title":"Veru Q2 EPS $(0.12) Beats $(0.28) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783940","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783940?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:31","pubTimestamp":1778668275,"startTime":"0","endTime":"0","summary":"Veru (NASDAQ:VERU) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.28) by 57.14 percent. This is a 76 percent increase over losses of $(0.50) per share from the same period","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52516696/veru-q2-eps-0-12-beats-0-28-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","VERU","BK4584","BK4183","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783613","title":"Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2B Plateau Clinical Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635783613?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:30","pubTimestamp":1778668200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA8TSTV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","VERU","BK4183","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635839027","title":"Press Release: Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2635839027","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635839027?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:30","pubTimestamp":1778668200,"startTime":"0","endTime":"0","summary":"--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027--. --Company to host conference call and webcast today at 8:00 a.m. ET--. \"We are extremely pleased with the progress of the enrollment of the Phase 2b PLATEAU clinical trial to evaluate the effect of enobosarm 3mg on total body weight, fat mass, lean mass, physical function, bone mineral density and safety in older patients who have obesity and receiving a semaglutide GLP-1 RA treatment for weight reduction. We are on track for presenting the results of the interim analysis which is expected in Q1 calendar year 2027,\" said Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer of Veru Inc.Semaglutide was selected as the GLP-1 RA for the Phase 2b PLATEAU study to build on Veru's previous clinical experience using enobosarm in combination with semaglutide in the positive Phase 2 QUALITY clinical study. Further, th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4584","LU2065732104.USD","BK4557","PRGS","R","BK4007","BK4232","VERU","BK4022","BK4097"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":63,"code":"91000000","status":"200"}]}}